151 related articles for article (PubMed ID: 10731128)
1. Optimizing therapy: tazarotene in combination with phototherapy.
Lowe NJ
Br J Dermatol; 1999 Apr; 140 Suppl 54():8-11. PubMed ID: 10731128
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene plus UVB phototherapy in the treatment of psoriasis.
Koo JY; Lowe NJ; Lew-Kaya DA; Vasilopoulos AI; Lue JC; Sefton J; Gibson JR
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):821-8. PubMed ID: 11050587
[TBL] [Abstract][Full Text] [Related]
3. Tazarotene in combination with phototherapy.
Koo JY
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S144-8. PubMed ID: 9777793
[TBL] [Abstract][Full Text] [Related]
4. Interactions between tazarotene and ultraviolet light.
Hecker D; Worsley J; Yueh G; Kuroda K; Lebwohl M
J Am Acad Dermatol; 1999 Dec; 41(6):927-30. PubMed ID: 10570375
[TBL] [Abstract][Full Text] [Related]
5. Tazarotene gel with narrow-band UVB phototherapy: a synergistic combination in psoriasis.
Dayal S; Kaura R; Sahu P; Jain VK
An Bras Dermatol; 2018 Jun; 93(3):385-390. PubMed ID: 29924221
[TBL] [Abstract][Full Text] [Related]
6. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel.
Behrens S; Grundmann-Kollmann M; Schiener R; Peter RU; Kerscher M
J Am Acad Dermatol; 2000 Mar; 42(3):493-5. PubMed ID: 10688723
[TBL] [Abstract][Full Text] [Related]
7. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
Tzaneva S; Hönigsmann H; Tanew A; Seeber A
Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
[TBL] [Abstract][Full Text] [Related]
8. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
[TBL] [Abstract][Full Text] [Related]
9. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.
Gollnick H; Menter A
Br J Dermatol; 1999 Apr; 140 Suppl 54():18-23. PubMed ID: 10731130
[TBL] [Abstract][Full Text] [Related]
11. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
Roeder A; Schaller M; Schäfer-Korting M; Korting HC
Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
[TBL] [Abstract][Full Text] [Related]
12. Receptor-selective retinoids for psoriasis: focus on tazarotene.
Weindl G; Roeder A; Schäfer-Korting M; Schaller M; Korting HC
Am J Clin Dermatol; 2006; 7(2):85-97. PubMed ID: 16605289
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
[TBL] [Abstract][Full Text] [Related]
14. Optimizing treatment with topical tazarotene.
Guenther LC
Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study.
Ring J; Kowalzick L; Christophers E; Schill WB; Schöpf E; Ständer M; Wolff HH; Altmeyer P
Br J Dermatol; 2001 Mar; 144(3):495-9. PubMed ID: 11260005
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis.
Koo J; Behnam SE; Behnam SM
Expert Opin Pharmacother; 2003 Dec; 4(12):2347-54. PubMed ID: 14640932
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis.
Kircik LH; Papp KA; Stein Gold L; Harris S; Pharm TL; Pillai R
J Drugs Dermatol; 2019 Mar; 18(3):279-284.. PubMed ID: 30909333
[TBL] [Abstract][Full Text] [Related]
19. Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy.
Tanghetti E; Lebwohl M; Stein Gold L
J Drugs Dermatol; 2018 Dec; 17(12):1280-1287. PubMed ID: 30586259
[TBL] [Abstract][Full Text] [Related]
20. [Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
Sander P; Happe M; Stücker M; Hermes N; Hoffmann K; Altmeyer P
Hautarzt; 1999 Oct; 50(10):723-7. PubMed ID: 10550358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
